Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast in prediabetic obese subjects
NCT04800172Phase 3Completed
- Sponsor
- Tanta University
- Start
- May 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roflumilast in obesity, prediabetes, sponsored by Tanta University. Started May 2021; status: completed.
02
Drugs
roflumilast
03
Conditions
obesityprediabetes
Beyond the preview
Go deeper on NCT04800172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04800172.